Guardant Health has received an expanded Medicare local coverage determination for its Guardant360 liquid biopsy test, broadening its coverage to all solid tumors outside of the central nervous system.
In this video, you’ll see an interview with President and CEO of Protean BioDiagnostics, Tony Magliocco, and Precision Cancer Medicine Patient Educator and A…
Nanostics and Protean partner to offer CDX Prostate risk score as a diagnostic tool to men suspected of having aggressive prostate cancer in the USA.
Nanostics and Protean partner to offer CDX Prostate risk score as a diagnostic tool to men suspected of having aggressive prostate cancer in the USA.
Dr. Tony Magliocco of the Moffit Cancer Center joins us to discuss the indepensible role of pathologists in precision medicine and the importance of technology…
Anthony Magliocco, MD is a cancer expert with over 30 years of experience.In this video he explains why someone might be diagnosed with a ‘cancer…
Protean and Roche have created a novel project to accelerate access to precision oncology for community based oncology programs.
New research suggests stars in the Milky Way give off infrared heat expected from Dyson spheres, which physicist Freeman Dyson theorized could be created by…
Cancer Informant is a podcast made to inform cancer patients and their loved ones about their options for cancer testing and treatment. Dr. Tony Magliocco…
Learn more about how prostate cancer is detected, risk factors, and treatments on our full video. Watch the full video on prostate cancer by clicking…
Aventa Genomics has launched its next-generation sequencing (NGS) test, Aventa FusionPlus, to identify gene fusions and translocations.
